Compared to healthy individuals, nighttime BMAL1 expression levels have been observed to be significantly lower in PD-patient cohorts (which included patients who had previously received, or were currently receiving, medication to treat PD as well as unmedicated individuals – known as drug-naïve patients) [18, 166]. The gene discussed is BMAL1; the disease is Parkinson disease.